82 related articles for article (PubMed ID: 9207350)
21. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus.
Xu J; Lyons PA; Carter MD; Booth TW; Davis-Poynter NJ; Shellam GR; Scalzo AA
J Gen Virol; 1996 Jan; 77 ( Pt 1)():49-59. PubMed ID: 8558128
[TBL] [Abstract][Full Text] [Related]
22. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
Zhang C; Pass RF
Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
[TBL] [Abstract][Full Text] [Related]
23. Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family.
Newkirk MM; Gram H; Heinrich GF; Ostberg L; Capra JD; Wasserman RL
J Clin Invest; 1988 May; 81(5):1511-8. PubMed ID: 2452836
[TBL] [Abstract][Full Text] [Related]
24. Deficiency in antibody response to human cytomegalovirus glycoprotein gH in human immunodeficiency virus-infected patients at risk for cytomegalovirus retinitis.
Rasmussen L; Morris S; Wolitz R; Dowling A; Fessell J; Holodniy M; Merigan TC
J Infect Dis; 1994 Sep; 170(3):673-7. PubMed ID: 7915750
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
Hiramatsu K; Tadano M; Men R; Lai CJ
Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
[TBL] [Abstract][Full Text] [Related]
26. Virolysis and in vitro neutralization of HIV-1 by humanized monoclonal antibody hNM-01.
Nakamura M; Terada M; Sasaki H; Kamada M; Ohno T
Hybridoma; 2000 Dec; 19(6):427-34. PubMed ID: 11152394
[TBL] [Abstract][Full Text] [Related]
27. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
28. Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus.
Alvi AZ; Stadnyk LL; Nagata LP; Fulton RE; Bader DE; Roehrig JT; Suresh MR
Hybridoma; 1999 Oct; 18(5):413-21. PubMed ID: 10600028
[TBL] [Abstract][Full Text] [Related]
29. Humanized antibodies for antiviral therapy.
Co MS; Deschamps M; Whitley RJ; Queen C
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2869-73. PubMed ID: 1849279
[TBL] [Abstract][Full Text] [Related]
30. Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion.
Lopper M; Compton T
J Virol; 2004 Aug; 78(15):8333-41. PubMed ID: 15254205
[TBL] [Abstract][Full Text] [Related]
31. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
[TBL] [Abstract][Full Text] [Related]
32. Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
Gardner TJ; Tortorella D
Microbiol Mol Biol Rev; 2016 Sep; 80(3):663-77. PubMed ID: 27307580
[TBL] [Abstract][Full Text] [Related]
33. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
34. A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.
Babcook JS; Leslie KB; Olsen OA; Salmon RA; Schrader JW
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7843-8. PubMed ID: 8755564
[TBL] [Abstract][Full Text] [Related]
35. Expression of the glycoprotein H of murine cytomegalovirus and identification of an N-terminal antibody-binding region.
Xu J; Scalzo AA; Lyons PA; Shellam GR
Virology; 1994 Oct; 204(1):466-70. PubMed ID: 7522376
[TBL] [Abstract][Full Text] [Related]
36. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus.
Chou S
J Infect Dis; 1992 Sep; 166(3):604-7. PubMed ID: 1323623
[TBL] [Abstract][Full Text] [Related]
38. Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.
van der Beek MT; Berger SP; Vossen AC; van der Blij-de Brouwer CS; Press RR; de Fijter JW; Claas EC; Kroes AC
Transplantation; 2010 Feb; 89(3):320-6. PubMed ID: 20145523
[TBL] [Abstract][Full Text] [Related]
39. Association between antibody response against cytomegalovirus strain-specific glycoprotein H epitopes and HLA-DR.
Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Shishido K; Aikawa K; Yamaguchi O; Toma H; Tanabe K; Suzutani T
Microbiol Immunol; 2009 Jul; 53(7):412-6. PubMed ID: 19563400
[TBL] [Abstract][Full Text] [Related]
40. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
